214 related articles for article (PubMed ID: 16979301)
1. Ascites is the primary cause of cancer antigen-125 (CA-125) elevation in systemic lupus erythematosus (SLE) patients with nephrotic syndrome.
Basaran A; Zafer Tuncer S
Med Hypotheses; 2007; 68(1):197-201. PubMed ID: 16979301
[TBL] [Abstract][Full Text] [Related]
2. Lack of correlation between tumor markers (CA 125 and SCC) and systemic lupus erythematosus activity.
Miret C; Font J; Molina R; Filella X; Vivancos J; Muñoz-Rodriguez FJ; Cervera R; Ballesta AM; Ingelmo M
Anticancer Res; 1998; 18(2B):1341-4. PubMed ID: 9615813
[TBL] [Abstract][Full Text] [Related]
3. Ascites, pleural effusion, and CA 125 elevation in an SLE patient, either a Tjalma syndrome or, due to the migrated Filshie clips, a pseudo-Meigs syndrome.
Tjalma WA
Gynecol Oncol; 2005 Apr; 97(1):288-91. PubMed ID: 15790480
[TBL] [Abstract][Full Text] [Related]
4. Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study.
Topalak O; Saygili U; Soyturk M; Karaca N; Batur Y; Uslu T; Erten O
Gynecol Oncol; 2002 Apr; 85(1):108-13. PubMed ID: 11925128
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of serum CA125 in nephrotic syndrome.
Peng T; Guo L; Xia Q; Yang X
Clin Lab; 2012; 58(1-2):113-5. PubMed ID: 22372353
[TBL] [Abstract][Full Text] [Related]
6. Unspecific increase of tumor markers in a girl with nephrotic syndrome and ovarian teratoma.
Kilis-Pstrusinska K; Szajerka U; Zwolinska D
Ren Fail; 2013; 35(5):654-6. PubMed ID: 23560847
[TBL] [Abstract][Full Text] [Related]
7. Coexistence of struma ovarii with marked ascites and elevated CA-125 levels: case report and literature review.
Mui MP; Tam KF; Tam FK; Ngan HY
Arch Gynecol Obstet; 2009 May; 279(5):753-7. PubMed ID: 18807056
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum CA-125 levels in patients with nephrotic syndrome-induced ascites.
Sevinc A; Buyukberber S; Sari R; Turk HM; Ates M
Anticancer Res; 2000; 20(2B):1201-3. PubMed ID: 10810422
[TBL] [Abstract][Full Text] [Related]
9. Is there any relationship between massive ascites and elevated CA-125 in systemic lupus erythematosus? Case report and review of the literature.
Quintero-Muñoz E; Gómez Pineda MA; Araque Parra C; Vallejo Castillo CA; Ortega Marrugo V; Bonilla Jassir J; Polo Nieto JF; Parra-Medina R; Rojas-Villarraga A
Mod Rheumatol Case Rep; 2021 Jul; 5(2):292-299. PubMed ID: 33783326
[TBL] [Abstract][Full Text] [Related]
10. Significance of serum tumor markers carcinoembryonic antigen, CA 19-9, CA 125, and CA 15-3 in pre-orthotopic liver transplantation evaluation.
Pissaia A; Bernard D; Scatton O; Soubrane O; Conti F; Calmus Y
Transplant Proc; 2009 Mar; 41(2):682-4. PubMed ID: 19328956
[TBL] [Abstract][Full Text] [Related]
11. Pericardial effusion in the nephrotic syndrome.
Göbel U; Mauersberger B; Kettritz R; Bohlender J; Luft FC
Clin Nephrol; 2002 Nov; 58(5):329-32. PubMed ID: 12425481
[TBL] [Abstract][Full Text] [Related]
12. [Longstanding intractable massive ascites caused by chronic lupus peritonitis with nephrotic syndrome: a case report].
Fuke Y; Ikeda K; Shimizu C; Kajiwara M; Ito K; Satomura A; Fujita T; Matsumoto K
Nihon Jinzo Gakkai Shi; 2009; 51(8):1067-74. PubMed ID: 19999586
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
[TBL] [Abstract][Full Text] [Related]
14. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
Gadducci A; Tana R; Cosio S; Genazzani AR
Crit Rev Oncol Hematol; 2008 Apr; 66(1):10-20. PubMed ID: 17964182
[TBL] [Abstract][Full Text] [Related]
15. Rapid onset of massive ascites as the initial presentation of systemic lupus erythematosus.
Weinstein PJ; Noyer CM
Am J Gastroenterol; 2000 Jan; 95(1):302-3. PubMed ID: 10638605
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
Kuryliszyn-Moskal A; Ciolkiewicz M; Klimiuk PA; Sierakowski S
Scand J Rheumatol; 2009; 38(1):38-45. PubMed ID: 18991188
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus.
Heshmat NM; El-Kerdany TH
Pediatr Allergy Immunol; 2007 Jun; 18(4):346-53. PubMed ID: 17346298
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
19. Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients.
Morgan PE; Sturgess AD; Davies MJ
Free Radic Res; 2009 Feb; 43(2):117-27. PubMed ID: 19096973
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of Ca 125 levels during primary therapy.
Markmann S; Gerber B; Briese V
Anticancer Res; 2007; 27(4A):1837-9. PubMed ID: 17649781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
